XML 51 R42.htm IDEA: XBRL DOCUMENT v3.23.2
RESTATEMENT (Tables)
9 Months Ended
Jun. 30, 2023
RESTATEMENT  
Schedule of impacts of error corrections

ii. Statement of operations

Impact of correction of error - quarter

Impact of correction of error - year to date

Quarter ended June 30, 2022 (Unaudited)

    

As previously

    

Adjustments

    

As restated

    

As previously

    

Adjustments

    

As restated

reported

reported

Loss from operations

(18,221,165)

-

(18,221,165)

(62,732,442)

-

(62,732,442)

Other financing costs - initial recognition of warrants at fair value

-

-

-

-

(269,344,177)

(269,344,177)

Gain / (loss) on derivative liability revaluation

3,045,000

31,538,523

34,583,523

3,045,000

(110,750,006)

(107,705,006)

Incentive fee to creditor for transfer of note payable

(23,085,886)

23,085,886

-

(23,085,886)

23,085,886

-

Others

(21,209,509)

-

(21,209,509)

(45,735,556)

-

(45,735,556)

Other income (expense)

(41,250,395)

54,624,409

13,374,014

(65,776,442)

(357,008,297)

(422,784,739)

Net loss

(59,471,560)

54,624,409

(4,847,151)

(128,508,884)

(357,008,297)

(485,517,181)

Deemed dividend on preferred stock

(2,285,792)

-

(2,285,792)

(4,805,740)

(32,735,345)

(37,541,085)

Net loss attributable to common stockholders

(61,757,352)

54,624,409

(7,132,943)

(133,314,624)

(389,743,642)

(523,058,266)

Loss per share

(36.88)

(4.26)

(176.93)

(694.20)

Weighted average common shares outstanding (after reverse stock splits, see Note 1)

1,674,607

1,674,607

753,474

753,474